SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories informs about newspaper publication

13 Mar 2026 Evaluate
Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Brooks Laboratories has enclosed newspaper publications relating to ‘Special Window for Re-lodgement of Transfer Request of Physical Shares’ as per SEBI Circular No. HO/38/13/11(2)/2026- MIRSD-POD/I/3750/2026 dated January 30, 2026 as published in the following newspapers: Financial Express (all edition) on 13th March 2026; Jansatta, (Chandigarh edition) on 13th March 2026. The same is also available on the website of the Company i.e., https://www.brookslabs.net

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

72.29 0.90 (1.26%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×